<?xml version="1.0" encoding="UTF-8"?>
<p>The main clinical characteristics of chronic patients in our study were consistent with previous descriptions [
 <xref rid="pntd.0007327.ref008" ref-type="bibr">8</xref>,
 <xref rid="pntd.0007327.ref024" ref-type="bibr">24</xref>,
 <xref rid="pntd.0007327.ref038" ref-type="bibr">38</xref>]: polyarthralgia, articular stiffness, swollen joints, and arthritis. Moreover, as was the case in previous studies [
 <xref rid="pntd.0007327.ref038" ref-type="bibr">38</xref>,
 <xref rid="pntd.0007327.ref072" ref-type="bibr">72</xref>–
 <xref rid="pntd.0007327.ref074" ref-type="bibr">74</xref>], enthesitis and tenosynovitis were observed in our cohort. One study reported relapsing arthralgia for the majority of examined patients [
 <xref rid="pntd.0007327.ref040" ref-type="bibr">40</xref>]. In our study, the development of CCA was associated with at least 1 tenosynovitis or 1 enthesitis in the acute phase. These 2 conditions, which are highly specific to symptomatic CHIKV infection, have not yet been identified as risk factors for CCA [
 <xref rid="pntd.0007327.ref075" ref-type="bibr">75</xref>–
 <xref rid="pntd.0007327.ref077" ref-type="bibr">77</xref>].
</p>
